Lowenstein Reps BASF In Deal For Biotech Co. Verenium

Law360, New York (September 20, 2013, 4:30 PM EDT) -- Chemical company BASF Corp. will acquire industrial biotechnology company Verenium Corp., which serves the global food and fuel industries, for about $4 per share, the companies said Friday.

Verenium has about 12.8 million shares outstanding, which would value the deal at about $51 million. The deal is expected to close in the fourth quarter of 2013. The acquisition will bolster BASF’s role in the efficient enzyme space, according to a statement issued by BASF.

“Combining Verenium’s scientific and technological excellence with BASF’s enzyme activities and its...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.